KE / Domain	AOP entity (KE/KER)	Input (manipulation / sample)	Method / Assay (SOP notes)	Output / Measurement	Interpretation / Context fields to capture	Exemplar peer-reviewed manuscripts	Protocol / SOP notes (attach)	S&T considerations (ontology / mapping)
Mucin production (increased) via EGFR	KE: Goblet cells, increased (Event 6); KE: Mucin, increased (Event 9); KER: EGFR activation → Goblet cells ↑ → Mucin ↑	Human airway epithelial cells; rodent tracheal models; EGF or TGF-α stimulation	Mucin gene expression by RT-PCR or Northern blot (MUC5AC, MUC5B). Mucin protein quantification by ELISA or dot blot. Histological staining for mucin (Alcian Blue, PAS staining). Immunohistochemistry for Muc5AC protein. Goblet cell enumeration in tissue sections.	MUC5AC and MUC5B mRNA levels; Mucin protein concentration (µg/mL); Alcian Blue/PAS-positive goblet cell counts; Muc5AC immunostaining intensity; Dose-response to EGFR agonists	Cell or tissue type; species; EGF/TGF-α concentration; stimulation duration; RT-PCR primers; ELISA antibody specifics; histological staining protocol; microscopy and quantification method; normalization approach; replicate number	Takeyama K, Dabbagh K, Lee HM, Agustí C, Lausier JA, Ueki IF, Grattan KM, Nadel JA. (1999). Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci U S A. 96(6):3081-6.	Include EGF/TGF-α dosing, RT-PCR or Northern blot protocol, mucin ELISA procedure, histological processing and staining (Alcian Blue/PAS, immunohistochemistry), image analysis for goblet cell counting, quantification methods	Biolink: MeasurementProcess; OBI: RT-PCR, ELISA, histology; Mapping: KE goblet cell increase (Event 6), KE mucin increase (Event 9), KER EGFR → goblet → mucin; Gene: MUC5AC, MUC5B; EGFR pathway
Goblet cell differentiation from FoxJ1+ progenitors	KE: Goblet cells, increased (Event 6); FoxJ1-expressing progenitor cells give rise to goblet cells in human airway	Primary human airway epithelial cells at ALI; lineage tracing; differentiation time-course	Immunofluorescence for goblet cell markers (Muc5AC) and FoxJ1. Dual-labeling to track progenitor-to-goblet cell transition. Confocal microscopy and cell quantification. Histology with Alcian Blue/PAS staining. Time-course analysis of differentiation. Cell type ratio quantification.	Percentage of Muc5AC+ goblet cells; Percentage of FoxJ1+ cells; Goblet cell to ciliated cell ratio; Time-course of goblet cell appearance; Lineage relationship data	Donor characteristics; passage number; differentiation medium; days at ALI; sampling timepoints; antibodies for immunofluorescence; staining protocols; confocal imaging parameters; cell counting methodology; statistical analysis	Turner et al. (2012). Goblet cells are derived from a FoxJ1-expressing progenitor in a human airway epithelium. Dev Cell. 22(4):821-9.	Include ALI differentiation protocol, immunofluorescence dual-staining procedure, confocal imaging settings, cell classification and counting criteria, time-course experimental design, lineage analysis approach	Biolink: MeasurementProcess; OBI: immunofluorescence assay; Mapping: KE goblet cell increase, developmental origin; Gene: FOXJ1, MUC5AC; Cell lineage; Differentiation dynamics
Goblet cell hyperplasia and mucin secretion (contemporary)	KE: Goblet cells, increased (Event 6); KE: Mucin, increased (Event 9); in vitro and in vivo models	Primary human airway epithelial cells at ALI; in vivo rodent models; environmental or inflammatory stimuli	Multi-modal goblet cell and mucin assessment. Histology with Alcian Blue/PAS for goblet cells. Immunofluorescence for Muc5AC and Muc5B proteins. qRT-PCR for MUC gene expression. Mucin ELISA in apical secretions or tissue homogenates. High-content imaging and automated quantification.	Goblet cell count and percentage; Mucin gene expression (MUC5AC, MUC5B); Mucin protein levels in secretions; Muc5AC/B immunofluorescence intensity; Automated high-content analysis metrics	Model system (in vitro ALI, in vivo); donor/animal characteristics; exposure or stimulation conditions; tissue processing; histology protocols; antibodies; qRT-PCR primers and normalization; ELISA platform; imaging system and analysis software; replicate number	Le et al. (2025). [Goblet cell and mucin regulation].	Document tissue processing and staining, immunofluorescence protocol, qRT-PCR methods, ELISA procedures, high-content imaging workflow, automated analysis algorithms, quality control measures	Biolink: MeasurementProcess; OBI: histology, immunofluorescence, qRT-PCR, ELISA; Mapping: KE goblet cells ↑, KE mucin ↑; Gene: MUC5AC, MUC5B; Multi-modal integration
Goblet cell and mucin assessment (toxicology endpoint)	KE: Goblet cells, increased (Event 6); KE: Mucin, increased (Event 9); response to tobacco product exposures	MucilAir™ 3D bronchial epithelial model at ALI; 28-day repeated exposure to heated tobacco aerosol or cigarette smoke	Histological assessment of goblet cells using Alcian Blue staining. Immunohistochemistry for Muc5AC protein. Quantification of goblet cell numbers and mucin staining intensity. Morphological evaluation of epithelial architecture. Correlation with other endpoints (cilia, inflammation).	Goblet cell count per field; Percentage of Alcian Blue-positive cells; Muc5AC staining intensity and distribution; Changes over 28-day exposure period; Correlation with functional impairment	3D culture model (MucilAir™); donor information; days at ALI; exposure regimen (dose, duration, frequency); tissue fixation and processing; staining protocols (Alcian Blue, Muc5AC IHC); imaging parameters; quantification method; baseline comparison; replicate number	Chapman et al. (2023). Twenty-eight day repeated exposure of human 3D bronchial epithelial model to heated tobacco aerosols indicates decreased toxicological responses compared to cigarette smoke. Toxicol Rep.	Include tissue processing workflow, Alcian Blue staining protocol, Muc5AC immunohistochemistry procedure, imaging acquisition, quantification methodology, quality control for staining consistency, integration with other toxicology endpoints	Biolink: MeasurementProcess; OBI: histology, immunohistochemistry; Mapping: KE goblet cells ↑, KE mucin ↑; Toxicology assessment; Repeated exposure model; Multi-endpoint integration
Mucin and goblet cell multi-endpoint analysis	KE: Goblet cells, increased (Event 6); KE: Mucin, increased (Event 9); comprehensive epithelial assessment	MucilAir™ 3D airway epithelium at ALI; e-cigarette aerosol or cigarette smoke exposure	Integrated assessment of goblet cell and mucin endpoints. Histology (Alcian Blue/H&E). Immunohistochemistry for Muc5AC. Gene expression analysis for mucin genes. Cell type balance assessment (goblet vs ciliated cell ratio). Functional correlation with mucociliary clearance.	Goblet cell percentage; Mucin gene expression; Muc5AC protein levels; Goblet-to-ciliated cell ratio; Integration with MCT and other functional endpoints	Culture model; exposure conditions; histology and immunostaining protocols; gene expression methods; imaging and quantification approaches; cell type classification criteria; functional assay correlation; replicate design	Czekala et al. (2021). Multi-endpoint analysis of human 3D airway epithelium following repeated exposure to whole electronic vapor product aerosol or cigarette smoke.	Document comprehensive protocol covering histology, IHC, gene expression, cell type quantification, and integration of morphological and functional data; quality metrics for each endpoint	Biolink: MeasurementProcess; OBI: multiple assay types; Mapping: KE goblet cells ↑, KE mucin ↑; Multi-endpoint systems approach; Cell type balance; Functional integration
Mucin gene expression by RNA-seq	KE: Mucin, increased (Event 9); transcriptomic assessment of mucin gene family	3D organotypic human airway cultures; e-cigarette aerosol vs cigarette smoke exposure; RNA-seq	RNA-seq for genome-wide expression including mucin gene family (MUC1, MUC4, MUC5AC, MUC5B, MUC16, etc.). Differential expression analysis. Gene set enrichment for mucin-related pathways. qRT-PCR validation of key mucin genes. Correlation with protein-level mucin data.	Expression levels of MUC5AC, MUC5B, and other mucin genes; Log2 fold changes; Differential expression statistics; Pathway enrichment scores; qRT-PCR validation; Protein-RNA correlation	Culture model; exposure protocol; RNA extraction and QC; sequencing platform and depth; bioinformatics workflow; differential expression criteria; pathway databases; validation gene selection; normalization method; batch correction	Haswell et al. (2017). Reduced biological effect of e-cigarette aerosol compared to cigarette smoke evaluated in vitro using normalized nicotine dose and RNA-seq-based toxicogenomics.	Include RNA extraction protocol, library prep, sequencing parameters, bioinformatics pipeline (alignment, quantification, DE analysis), pathway analysis methods, qRT-PCR validation, integration with protein/morphology data	Biolink: MeasurementProcess; OBI: RNA-seq assay; Mapping: KE mucin increase; Gene: MUC5AC, MUC5B, mucin gene family; Transcriptomics; Multi-omics integration potential
Inflammatory regulation of mucin production	KE: Mucin, increased (Event 9); inflammatory signaling pathways regulating mucin	Human bronchial epithelial cells; inflammatory cytokine stimulation or oxidative stress	Mucin gene expression in response to inflammatory mediators (IL-1β, TNF-α, IL-13). qRT-PCR for MUC5AC and MUC5B. Western blot or ELISA for mucin proteins. EGFR and MAPK signaling pathway assessment. NF-κB activation assays. Inhibitor studies to dissect pathways.	MUC5AC and MUC5B mRNA levels; Mucin protein expression; EGFR/MAPK/NF-κB activation; Cytokine dose-response; Pathway inhibitor effects on mucin production	Cell type; inflammatory stimulus type and concentration; exposure duration; qRT-PCR primers and controls; Western blot/ELISA antibodies; pathway inhibitors used; signaling assay methods; normalization approach; replicate number	Huang et al. (2017). [Inflammatory regulation of mucin in airways].	Include cytokine stimulation protocol, qRT-PCR methods, Western blot/ELISA procedures, signaling pathway assays, inhibitor validation, time-course and dose-response experimental design	Biolink: MeasurementProcess; OBI: qRT-PCR, Western blot, ELISA; Mapping: KE mucin increase, inflammatory signaling pathways; Gene: MUC5AC, MUC5B; Pathway: EGFR, MAPK, NF-κB; Mechanistic linkage
